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Abstract
Numerous studies have stated that humans need to utilise full sun radiation, at certain
times of the day, to assist the body in synthesising the required levels of vitamin D3.
The time needed to be spent in the full sun depends on a number of factors, for exam-
ple, age, skin type, latitude, solar zenith angle. Current Australian guidelines suggest5
exposure to approximately 1/6 to 1/3 of a minimum erythemal dose (MED), depending
on age, would be appropriate to provide adequate vitamin D3 levels. The aim of the
study was to determine the exposure times to diffuse solar UV to receive exposures
of 1/6 and 1/3 MED for a changing solar zenith angle in order to assess the possible
role that diffuse UV (scattered radiation) may play in vitamin D3 effective UV expo-10
sures (UVD3). Diffuse and global erythemal UV measurements were conducted at five
minute intervals over a twelve month period for a solar zenith angle range of 4
◦
to 80
◦
at
a latitude of 27.6
◦
S. For diffuse UV exposures of 1/6 and 1/3 MED, solar zenith angles
smaller than 60
◦
and 50
◦
respectively can be utilised for exposure times of less than
10min. Spectral measurements showed that, for a solar zenith angle of 40
◦
, the UVA15
(315–400 nm) in the diffuse component of the solar UV is reduced by approximately
62% compared to the UVA in the global UV, whereas UVD3 wavelengths are only re-
duced by approximately 43%. At certain latitudes, diffuse UV under shade may play an
important role in providing the human body with adequate levels of UVD3 (290–330 nm)
radiation without experiencing the high levels of damaging UVA observed in full sun.20
1 Introduction
The health effects of solar UV radiation vary significantly, from initiating the synthesis of
vitamin D3 to the severe degradation of the human body. Excessive solar UV radiation
exposure led to the premature deaths of approximately 60 000 people in the year 2000
(Lucas et al., 2006). It is well known that exposure to small amounts of UV radiation are25
beneficial for the human body and important in the production of vitamin D3, whereas
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excessive exposure to sunlight is known to cause skin cancer, immune suppression,
DNA damage, erythema and sun-related eye disorders (Baron et al., 2003; Glerup et
al., 2000; Terenetskaya, 2000; Sliney, 2004; Setlow et al., 1993). Approximately 90–
95% of our vitamin D3 requirement comes from exposure to the sun (Holick, 2004;
Holick, 1998). The synthesis of pre-vitamin D3 is initiated through exposure of human5
skin to terrestrial UV radiation from 290 to 330 nm. The longer wavelength UVA radia-
tion (greater than 330 nm) plays no part in the synthesis of pre-vitamin D3 in humans.
Although, over exposure to UV wavelengths is known to cause damage, vitamin D3
synthesis occurs at doses far below those needed for erythema to arise (Webb, 1993).
Current Australian guidelines suggest exposure to approximately 1/6 to 1/3 of a MED10
(minimum erythemal dose), depending on age, would be appropriate to provide ade-
quate vitamin D3 levels (Samanek et al., 2006; CDHAA, 2004). Older people require
more frequent exposures as vitamin D3 production rates are about 1/5 as high for the
elderly as for the young (Holick et al., 1989). Also, people with highly pigmented skin
would require exposures 3–4 times greater than those necessary for fair skinned peo-15
ple (Pathak et al., 1999). Recent research suggests that the optimal serum vitamin D3
level for bone health and protection against other diseases is between 800 and 2000
IU per day (Aloia and Li-Ng, 2007; Lappe et al., 2007; Vieth et al., 2007; Dawson-
Hughes et al., 2005); with 1000 IU equivalent to exposing 15% of the human body to
approximately 1/3 MED (PS, 2006). A position statement was recently approved by20
the Working Group of the Australian and New Zealand Bone and Mineral Society, En-
docrine Society, Osteoporosis Australia, Australian College of Dermatologists and the
Cancer Council Australia recommending five minutes solar UV exposure either side of
the peak UV periods on most days of the week in summer and approximately 2–3 h so-
lar UV exposure over a week in winter (PS, 2006). This position statement is still behind25
emerging scientific findings (e.g. Giovannucci et al., 2006; Grant et al., 2007; Gorham
et al., 2007; Garland et al., 2007). Nevertheless, it is still the most up to date statement
that has been distributed to the public. The position statement is also a generalized
report as sun exposure varies significantly with latitude and atmospheric conditions.
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Solar UV radiation is incident on the earth’s surface in two distinct components,
direct and diffuse. The direct component is straight forward to minimise by simply
blocking its path, whereas the diffuse component is incident from all directions and
is difficult to minimise. Atmospheric scattering which is influenced by factors such
as solar zenith angle (SZA), clouds and atmospheric constituents plays a major role5
in determining the proportions of UVB (280–315nm) and UVA (315–400 nm) in diffuse
UV, with greater scattering occurring at the shorter UVB wavelengths than at the longer
wavelength UVA. Turnbull et al. (2005) found that UVA was reduced by as much as
65% when utilising a shade umbrella, whereas UVB exposures were only reduced by
approximately 48%. Therefore, at certain SZA, the diffuse UV may provide adequate10
levels of the effective wavelengths needed for vitamin D3 production (UVD3), without
producing erythema. In comparison, mutagenic and carcinogenic effects on human
skin have been shown to be caused by exposure to UVA radiation (Agar et al., 2004;
Moan et al., 1999; Garland et al., 2003). Therefore, reducing personal exposures to
UVA radiation while still receiving sufficient amounts of the UVD3 wavelengths required15
to produce recommended vitamin D3 levels is essential.
The importance of this research is that it provides a basis for public health campaigns
aimed at reducing the incidence of hypovitaminosis D and its attendant disorders, as
well as reducing over exposure to harmful solar UV radiation. In the light of the con-
siderable body of evidence regarding the harm done by excessive UV exposure and20
the public awareness of skin cancer, any new public health program would need to
avoid confusing the public with seemingly opposing messages. Utilizing diffuse solar
UV radiation to obtain beneficial amounts of UV, while at the same time minimizing
personal overexposure to UVA radiation may prove to be absolutely necessary for an
improvement in public health. Studies have shown that shade structures are important25
as a UV minimisation strategy; however, shade settings may also play an important
role in providing exposures to the human body with adequate levels of UV radiation for
vitamin D3 production without experiencing the higher levels of UVA experienced in full
sun. The lengths of exposure to solar UV at noon in major Australian cities to produce
784
ACPD
8, 781–796, 2008
Utilising shade to
optimize UV
exposure for vitamin
D
D. J. Turnbull and
A. V. Parisi
Title Page
Abstract Introduction
Conclusions References
Tables Figures
◭ ◮
◭ ◮
Back Close
Full Screen / Esc
Printer-friendly Version
Interactive Discussion
EGU
exposures of 1/3 and 1/6 MED has previously been reported (Samanek et al., 2006).
This current paper extends this previous research to report on the lengths of exposure
periods required to produce these exposures for diffuse erythemal UV compared to
global erythemal UV for a range of SZA and cloud conditions encountered over a year.
2 Materials and methods5
2.1 Integrated automated cloud and spectral UV measurement system
An integrated automated cloud and spectral UV measurement system was employed at
a Southern Hemisphere site at Toowoomba, Australia (27.6
◦
S, 151.9
◦
E, 693m above
sea level) for automatically measuring every five minutes both the cloud fraction and
the UV spectrum. The system was located on the roof of a building with relatively10
unobstructed views and the surrounding topography does not provide any significant
obstruction to the field of view of the instruments.
The cloud detection system is a Total Sky Imager (TSI) (model TSI-440, Yankee
Environmental Systems, MA, USA) with approximately 160
◦
field of view of the sky.
The TSI consists of a CCD camera suspended over a hemispherical reflective dome15
that points upwards on a horizontal plane. For each image, digital analysis provides
the fraction of cloud cover as a number between 0 and 1 where 1 represents total cloud
cover. The uncertainty in the determination of the amount of cloud has been reported
as ±10% at least 95% of the time (Sabburg and Long, 2004).
The spectral UV measurement system is located within three metres of the cloud20
detection system and is housed in an environmentally sealed box with a fibre optic
connecting the diffuser to the input slit of the monochromator through a hole with a
seal around the fibre to protect the equipment inside the box from the environment.
The system is based on a double monochromator system model (DTM300, Bentham
Instruments, Reading, UK) with the gratings having 2400grooves/mm. The input and25
output slit widths on the monochromator of 0.37mm have been selected to provide a
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bandwidth of 0.5 nm. The spectral UV data was recorded from 280 to 400 nm in 0.5 nm
increments. The input optics are provided by a diffuser (model D6) with the manufac-
turer determined error associated with the cosine response as less than ±0.8% for a
SZA up to 70
◦
and ±3.3% for an SZA of 80
◦
. The system is scheduled to scan every
five minutes from 05:00 EST (Eastern Standard Time) to 17:00 EST and the start of5
the initialisation of a spectral scan is one minute before the TSI obtains an image of
the sky. This allows the spectral scan to start at approximately the same time that
the TSI takes the sky image. Wavelength and irradiance calibration of the spectral UV
system was undertaken by employing the 365 nm mercury spectral line and a 150Watt
quartz halogen lamp with calibration traceable to the National Physical Laboratory, UK10
standard.
2.2 Diffuse and global erythemal UV
Two erythemal UV meters (UV-Biometer Model 501, Solar Light Co., Philadelphia, PA,
USA) were employed to monitor the diffuse and global erythemal UV (UVery). The
diffuse UVery meter is a global UVery meter that has been specifically set up to measure15
the diffuse erythemal radiation. It utilizes a shadow band, which is aligned east-west,
to block the sun during the day. The shadow band is 0.076m wide and the distance
from the shadow band to the top of the diffuse UVery meter varies from 0.25m to
0.27m as it is moved with the seasons. The shadow band blocks out part of the sky
view and the amount blocked has been measured at approximately 10%. A correction20
has been applied to all of the data to account for this. The diffuse and global UVery
meters were set up to record data every five minutes. The meters are temperature
stabilized to 25
◦
C and calibrated twice a year during clear sky conditions against the
scanning spectroradiometer. The daily atmospheric column of ozone as obtained from
the TOMS (Total Ozone Mapping Spectrometer) ranged from 243.5 to 337.0DU and the25
SZA ranged from 4
◦
to 80
◦
over the twelve month measurement period from January
to December 2003.
786
ACPD
8, 781–796, 2008
Utilising shade to
optimize UV
exposure for vitamin
D
D. J. Turnbull and
A. V. Parisi
Title Page
Abstract Introduction
Conclusions References
Tables Figures
◭ ◮
◭ ◮
Back Close
Full Screen / Esc
Printer-friendly Version
Interactive Discussion
EGU
3 Results
3.1 Diffuse and global erythemal UV
An example of diffuse and global UV spectra is shown in Fig. 1a for a cloud free period
on 17 August 2005 at 11.55 EST for an SZA of 40
◦
. This illustrates the variation in the
relative proportions of the different wavelengths when comparing diffuse UV to global5
UV. For Fig. 1a, the diffuse spectral irradiance summed over the UVA waveband was
16.8W/m
2
compared to 44.5W/m
2
for the global UVA. Similarly, the diffuse UVB was
0.63W/m
2
compared to 1.12W/m
2
for global UVB. For this specific date and time, the
UVA was reduced by approximately 62% compared to the global UVA, whereas the
diffuse UVB was only reduced by approximately 44%. The ratio of the diffuse to global10
UV plotted on the right hand axis of Fig. 1b gives an indication of the change in ratio
when comparing global and diffuse UV wavelengths.
Figure 1b provides the global and diffuse solar UV spectra (from Fig. 1a) weighted
with the pre-vitamin D (CIE, 2006) action spectrum. Pre-vitamin D3 exposure was
reduced by 43% whereas UVA exposure was reduced by 64%. These spectral mea-15
surements were obtained using the spectral measurement system described earlier.
3.2 Exposure times for 1/6 and 1/3 MED
The times required for an exposure of 1/3 MED on a horizontal plane for SZA greater
than 4
◦
for the atmospheric and cloud conditions during 2003 are shown in Fig. 3a for
diffuse and Fig. 3b for global UVery. Over 25 000 data points are provided in each figure20
for diffuse and global UVery for all SZA, sky and atmospheric conditions encountered
over this period. The minimum time for an exposure of 1/3 MED due to diffuse UVery
was 4.2min for a SZA of 4
◦
. As shown in Fig. 3a and b, this data has been broken
down into separate cloud levels of 0 to 80% and 85 to 100%, respectively. This was
undertaken to illustrate that 0 to 80% of cloud cover has a lesser effect on the diffuse25
UVery compared to 85 to 100% of cloud.
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The times required for an exposure of 1/3 MED due to the diffuse and global UVery
on a horizontal plane expressed as a percentage of occurrence for 2003 are shown in
Fig. 4. For diffuse UVery, the maximum incidence for 1/3 MED was in the range of 5 to
10min with an occurrence of 34.9%, followed by 29.5% for 10 to 15min, and 17.8% for
15 to 20min. For global UVery, the maximum incidence of the times for 1/3 MED was in5
the range of 5 to 10min with an occurrence of 32.9%, followed by 26.7% for less than
or equal to 5min, and 17.9% for 10 to 15min.
4 Discussion
Studies on the levels of UV observed in the shade of different shade environments
have shown that the relative proportions of UVA and UVB in the shade are significantly10
different to those in full sun (Turnbull et al., 2005; Turnbull and Parisi, 2003; Turnbull
et al., 2003; Parisi et al., 2001). The relative proportions of the UVA in shade to those
in full sun are decreased compared to the relative proportions of the UVB in shade to
those in full sun. At certain latitudes and SZA, unprotected exposure for short periods
to the UV under shade structures may be the best course of action as it will contribute15
more toward vitamin D3 production than toward erythema compared to exposing the
body to full sun UV due to the reduced relative component of the UVA in the shade.
The minimum time for an exposure of 1/3 MED due to diffuse UVery was 4.2min for
a SZA of 4
◦
. These times are longer for larger SZA and for overcast conditions. For ex-
posures of 1/6 and 1/3 MED, SZA smaller than 60
◦
and 50
◦
respectively can be utilised20
for exposure times of less than 10min. For SZA between 4
◦
to 50
◦
, 94% of the data
shows that an exposure of 1/6 MED requires less than 10min of exposure to diffuse
UV. This extends to 20min for exposure to 1/3 MED. Although the measurements are
at one latitude, the data was collected for the SZA range of 4
◦
to 80
◦
. This will allow the
results to be applicable at latitudes that experience these SZA.25
The values provided in this paper are for pale skin and for a sky view that is not
blocked, apart from the blocking of the solar disc. For larger structures the amount
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of sky view will be reduced due to the structural components of the shade structure,
causing the exposure times required for the respective exposures due to the diffuse
UVery to be slightly longer. Nevertheless, the findings in this paper may have significant
ramifications for future public health policy regarding sun exposure, which is currently
being debated in many countries (Diffey, 2006; Gillie, 2006). Also, the findings of this5
research may prove useful to those that work from 09:00 a.m. to 05:00 p.m., where
solar UV exposure at noon or during a lunch break may be the only option for the
necessary UV exposures to initiate the synthesis of vitamin D3. Therefore, advice to
stay out of the sun in the middle of the day, which is best for vitamin D3 synthesis in the
skin, can be adjusted to advocate the possible use of appropriate shade environments.10
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Fig. 1. Diffuse (light line) and global (heavy line) spectral UV irradiances taken on 17 August
2005 at approximately 11:00 EST and the spectral ratio of diffuse to global UV (a); and global
and diffuse spectral irradiances from (a) weighted with the pre-vitamin D3 action spectrum (CIE,
2006).
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Fig. 2. The times required for an exposure of 1/3 MED due to diffuse UVery (a) and global UVery
(b) as a function of SZA for all sky conditions during 2003.
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Fig. 3. Times for exposure to 1/3 MED of diffuse UV for cloud cover of 0 to 80% (a) and 85 to
100% (b).
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Fig. 4. Histogram of the percentage of the occurrences when the time required for an exposure
of 1/3 MED due to diffuse (grey bar) and global (black bar) UVery falls within a certain time
range provided in units of minutes.
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